Prognostic Implications of MicoRNA miR-195 Expression in Human Tongue Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Jia, Ling Fei ^a   Wei, Su Bi ^b   Gong, Kai ^b   Gan, Ye Hua ^a   Yu, Guang Yan ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA; MICRORNA; MICRORNA 195; PROTEIN BCL 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; BINDING SITE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE PROGRESSION; CLINICAL EVALUATION; CONTROLLED STUDY; CYCLIN D1 GENE; DOWN REGULATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTO ONCOGENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONGUE CARCINOMA; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICRORNAS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE; TONGUE NEOPLASMS;

EID: 84874306402     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056634     Document Type: Article

References (47)

1. Leemans CR, Braakhuis BJ, Brakenhoff RH, (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
3. Yuen PW, Lam KY, Chan AC, Wei WI, Lam LK, (1998) Clinicopathological analysis of local spread of carcinoma of the tongue. Am J Surg 175: 242-244.
4. Po Wing Yuen A, Lam KY, Lam LK, Ho CM, Wong A, et al. (2002) Prognostic factors of clinically stage I and II oral tongue carcinoma-A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 24: 513-520.
5. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, et al. (2007) Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
7. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM, (2003) bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36.
8. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
9. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14: 2588-2592.
10. Jiang L, Liu X, Kolokythas A, Yu J, Wang A, et al. (2010) Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 127: 505-512.
11. Li J, Huang H, Sun L, Yang M, Pan C, et al. (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15: 3998-4008.
12. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T, (2003) New microRNAs from mouse and human. RNA 9: 175-179.
13. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
14. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, et al. (2009) Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125: 345-352.
15. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, et al. (2009) Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24: 652-657.
16. Liu L, Chen L, Xu Y, Li R, Du X, (2010) microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 400: 236-240.
17. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, et al. (2009) MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50: 113-121.
18. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, et al. (2009) miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. Clin Cancer Res 15: 7684-7692.
19. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505.
20. Marx J, (1994) How cells cycle toward cancer. Science 263: 319-321.
21. Li L, Backer J, Wong AS, Schwanke EL, Stewart BG, et al. (2003) Bcl-2 expression decreases cadherin-mediated cell-cell adhesion. J Cell Sci 116: 3687-3700.
22. Edge SB, Byrd DR, editors (2010) AJCC cancer staging manual (7th ed). New York, NY: Springer.
23. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
24. Wu YW, Bi YP, Kou XX, Xu W, Ma LQ, et al. (2010) 17-Beta-estradiol enhanced allodynia of inflammatory temporomandibular joint through upregulation of hippocampal TRPV1 in ovariectomized rats. J Neurosci 30: 8710-8719.
25. Jorgensen S, Baker A, Moller S, Nielsen BS, (2010) Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52: 375-381.
26. Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL, (2007) Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 310: 442-453.
27. Su H, Yang JR, Xu T, Huang J, Xu L, et al. (2009) MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69: 1135-1142.
28. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
29. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, et al. (2004) Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods 1: 155-161.
30. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
31. He JF, Luo YM, Wan XH, Jiang D, (2011) Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis. J Biochem Mol Toxicol 25: 404-408.
32. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, et al. (1993) Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 119: 1238-1243.
33. el-Naggar AK, Steck K, Batsakis JG, (1995) Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. Cytometry 21: 47-51.
34. Bova RJ, Quinn DI, Nankervis JS, Cole IE, Sheridan BF, et al. (1999) Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 5: 2810-2819.
35. Leonard JH, Kearsley JH, Chenevix-Trench G, Hayward NK, (1991) Analysis of gene amplification in head-and-neck squamous-cell carcinoma. Int J Cancer 48: 511-515.
36. Davidson BJ, Lydiatt WM, Abate MP, Schantz SP, Chaganti RS, (1996) Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma. Head Neck 18: 512-521.
37. Meredith SD, Levine PA, Burns JA, Gaffey MJ, Boyd JC, et al. (1995) Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch Otolaryngol Head Neck Surg 121: 790-794.
38. Yao L, Iwai M, Furuta I, (1999) Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol 35: 56-62.
39. Coutinho-Camillo CM, Lourenco SV, Nishimoto IN, Kowalski LP, Soares FA, (2010) Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma. Histopathology 57: 304-316.
40. de Vicente JC, Olay S, Lequerica-Fernandez P, Sanchez-Mayoral J, Junquera LM, et al. (2006) Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma. J Oral Pathol Med 35: 140-145.
41. Popovic B, Jekic B, Novakovic I, Lukovic LJ, Tepavcevic Z, et al. (2007) Bcl-2 expression in oral squamous cell carcinoma. Ann N Y Acad Sci 1095: 19-25.
42. Avissar M, Christensen BC, Kelsey KT, Marsit CJ, (2009) MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15: 2850-2855.
43. Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, et al. (2009) Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 174: 736-745.
44. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, et al. (2009) Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 18: 4818-4829.
45. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 1129-1139.
46. Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE, (2007) Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity? J Oral Maxillofac Surg 65: 229-236.
47. Shaw RJ, McGlashan G, Woolgar JA, Lowe D, Brown JS, et al. (2009) Prognostic importance of site in squamous cell carcinoma of the buccal mucosa. Br J Oral Maxillofac Surg 47: 356-359.